Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2056374Generated: November 2, 2026

[(2R)-8-methyl-2,3-dihydro[1,4]dioxino[2,3-f]quinolin-2-yl]methyl4-bromobenzenesulfonate → 2-[3-(6-Fluoro-1h-indol-3-ylmethyl)-piperidin-1-ylmethyl]-8-methyl-2,3-dihydro-[1,4]dioxino[2,3-f]quinoline

https://huagongshe.com/reaction/2056374

Reaction equation

Participants

RoleNameHCIDCharge
Reactant[(2R)-8-methyl-2,3-dihydro[1,4]dioxino[2,3-f]quinolin-2-yl]methyl4-bromobenzenesulfonateHCID 20624762—
Reactant6-Fluoro-3-piperidin-3-ylmethyl-1h-indoleHCID 21892076—
Product2-[3-(6-Fluoro-1h-indol-3-ylmethyl)-piperidin-1-ylmethyl]-8-methyl-2,3-dihydro-[1,4]dioxino[2,3-f]quinolineHCID 9980953—

Reaction Steps

This compound was prepared as described for Example 2, using (2R)-4-bromobenzenesulfonic acid 8-methyl-2,3-dihydro-[1,4]dioxino[2,3-f]quinolin-2-ylmethyl ester (0.22 g, 4.9 mmol), 6-fluoro-3-piperidin-3-ylmethyl-1H-indole (0.13 g, 5.9 mmol), to afford 0.11 g (50%) of the (S)-enantiomer of the title compound as a light brown oil. The hydrogen chloride salt was prepared in ethyl acetate and collected as 0.12 g of a yellow solid, m.p. 50° C. (dec).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07335666B2
Source datasetuspto-grants-2008_02
ORD IDord-ee1541480a3745ccb65a247c157b4308
Source noteuspto-grants-2008_02